• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12G filed by NeuroMetrix Inc.

    5/12/25 4:05:30 PM ET
    $NURO
    Medical/Dental Instruments
    Health Care
    Get the next $NURO alert in real time by email
    15-12G 1 ea0241106-1512g_steel.htm FORM 15-12G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 15

     

    CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

     

    Commission File Number:    001-33351

     

     

     

    NEUROMETRIX, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    4B Gill Street, Woburn,

    Massachusetts 01801

    Tel: (781) 890-9989

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

     

    Common stock, par value $0.0001 per share

    Preferred Stock Purchase Rights

     

    (Title of each class of securities covered by this Form)

     

    None

    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

     

     

     

    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

     

        Rule 12g-4(a)(1)   ☒
        Rule 12g-4(a)(2)   ☐
        Rule 12h-3(b)(1)(i)   ☒
        Rule 12h-3(b)(1)(ii)   ☐
        Rule 15d-6   ☐
        Rule 15d-22(b)   ☐

     

    Approximate number of holders of record as of the certification or notice date:

     

    Common Stock, $0.0001 par value   1*    
    Preferred Stock Purchase Rights   0*    

     

    *On May 1, 2025, pursuant to the Agreement and Plan of Merger, dated as of December 17, 2024, among NeuroMetrix, Inc. (the “Company”), electroCore, Inc. (“Parent”) and Nexus Merger Sub Inc. (“Merger Sub”), Merger Sub merged with and into the Company (the “Merger”), with the Company surviving the Merger as a subsidiary of Parent.

     

     

     

     

     

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

     

    Date: May 12, 2025

     

      NeuroMetrix, Inc.
       
      By: /s/ Joshua S. Lev
      Name: Joshua S. Lev
      Title: Chief Financial Officer and Secretary

     

     

     

     

    Get the next $NURO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NURO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NURO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Horowitz Joshua returned 90,307 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - NeuroMetrix, Inc. (0001289850) (Issuer)

      5/5/25 6:51:59 PM ET
      $NURO
      Medical/Dental Instruments
      Health Care
    • Director Goodman David returned 7,602 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - NeuroMetrix, Inc. (0001289850) (Issuer)

      5/5/25 5:53:03 PM ET
      $NURO
      Medical/Dental Instruments
      Health Care
    • Director Van Avermaete David returned 7,601 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - NeuroMetrix, Inc. (0001289850) (Issuer)

      5/5/25 5:53:02 PM ET
      $NURO
      Medical/Dental Instruments
      Health Care

    $NURO
    SEC Filings

    See more
    • SEC Form 15-12G filed by NeuroMetrix Inc.

      15-12G - NeuroMetrix, Inc. (0001289850) (Filer)

      5/12/25 4:05:30 PM ET
      $NURO
      Medical/Dental Instruments
      Health Care
    • SEC Form EFFECT filed by NeuroMetrix Inc.

      EFFECT - NeuroMetrix, Inc. (0001289850) (Filer)

      5/6/25 12:15:11 AM ET
      $NURO
      Medical/Dental Instruments
      Health Care
    • SEC Form EFFECT filed by NeuroMetrix Inc.

      EFFECT - NeuroMetrix, Inc. (0001289850) (Filer)

      5/6/25 12:15:15 AM ET
      $NURO
      Medical/Dental Instruments
      Health Care